 |
 |
 |
 |
 |
 |
 |
PhiloGene, Inc. Announces that VEGFbTM has been
Granted Orphan Drug Designation
by the FDA for the Treatment of Advanced MelanomaPhiloGene Inc. Announces Revolutionary Advances in the Treatment of Cancer and Macular Degeneration BIO National Venture Conference 2008
see our technology and pipeline
site under construction
PhiloGene Inc. is a biopharmaceutical company focused on developing and commercializing novel protein therapeutics for unmet medical and patient needs. PhiloGene' in-depth knowledge of protein therapeutics has resulted in a unique approaches that exploit the therapeutic potential of native growth and differentiation factors. As a company, we are committed to improving the quality of life of patients.
See BIO National Venture Conference 2008 presentation